Blog
Has Intuit Stock Climbed Too Far?
The pandemic has crippled many small businesses since they've contended with government-mandated closures and reduced foot traffic as consumers try to avoid COVID. Intuit (NASDAQ: INTU) built a
The Only Fuel Cell Stock That's a Buy
Fuel cell stocks have been on fire over the past year as investors speculate that hydrogen could be a growing fuel source over the next decade. But the bubble seems to be bursting with shares
1 Huge Warning Sign in Tonix Pharmaceuticals' Earnings
Shares of Tonix Pharmaceuticals (NASDAQ: TNXP) have been highly volatile since the company entered the race to develop a new COVID-19 vaccine. Investors saw this biotech stock double in February
OneConnect Financial Technology Co., Ltd. (OCFT) Q1 2021 Earnings Call Transcript
Image source: The Motley Fool.
OneConnect Financial Technology Co., Ltd. (NYSE: OCFT)Q1 2021 Earnings CallMay 12, 2021, 9:00 p.m. ET
Operator
Source Fool.com
Better Buy: Microsoft vs. Oracle
I compared Microsoft (NASDAQ: MSFT) to Oracle (NYSE: ORCL) about a year ago and declared the former was the better investment option.
At the time, I predicted investors would continue to pay a
Alphabet's Core Business Is Rocking
Alphabet (NASDAQ: GOOG)(NASDAQ: GOOGL) and its core business of advertising continues to post amazing growth and profit numbers. But what about its "other bets" segment that caused the company to
3 Things You Shouldn't Do if the Stock Market Crashes in May
For months, investors have been on the edge of their seats just waiting for their portfolio values to tumble. Stocks have been largely overvalued for months, and many believe that conditions are
PayPal Raised Its Outlook. Here's What You Need to Know
It's been a very good 12 months for PayPal Holdings (NASDAQ: PYPL). The digital payments company had a record 2020 thanks, in part, to the coronavirus pandemic and the increased need for people to
Why Did My Stock Drop After a Good Earnings Report?
It's earnings season. It's the time when most companies release earnings reports on the results of the most recent quarter. But all too often it seems that your favorite company reports a solid
Ollie's Bargain Outlet Is Putting Up Surprising Growth Numbers
Brick-and-mortar retailers have struggled throughout the pandemic, but Ollie's Bargain Outlet (NASDAQ: OLLI) has bucked the trend. Ollie's put up amazing numbers across the board last year, which
3 Top Stocks Under $10 That Are Already Down More Than 50%
Low stock prices can get even lower. We've seen that happen with the recent sharp correction in growth stocks. A lot of stocks that once had promise and momentum have fallen out of favor. Is that
3 Companies Getting Whacked by the Global Semiconductor Shortage
The global semiconductor shortage came about due to challenges manufacturing new chips, pandemic-related disruptions, the secular growth of new technologies, and elevated demand for consumer
Here's How Much You Could Be Making From Johnson & Johnson's Dividend 5 Years From Now
If you only look at a stock's current dividend yield, you could get an incomplete picture as to how much recurring revenue it can actually generate for you. Dividend growth is an important
Could Jushi Holdings Be a Millionaire-Maker Stock?
Making a million dollars from cannabis doesn't seem like an impossible feat given the industry's growth potential. By 2026, cannabis research company BDSA projects that the industry will be worth
Why Logitech International Is One of the Best Growth Stocks to Buy Right Now
Logitech International (NASDAQ: LOGI) is a classic example of a growth stock trading at a reasonable price, especially after its latest earnings report, which shows us that it can keep growing in a
3 Signs It's Time to Ditch Your 401(k)
As someone who writes about retirement planning a lot, I'm often asked whether it pays to take advantage of a 401(k) plan if there's one available. And generally, my answer is a resounding "yes."
Canopy Growth Stock Is Down More Than 50% From Its 52-Week High: Is Now the Time to Buy?
Canopy Growth (NASDAQ: CGC) released its fiscal 2020 third-quarter earnings report on Feb. 9. Its strong results for the period, which ended Dec. 31, helped drive its share price to a 52-week high
Does Pfizer's Latest News Snatch a Big Market Opportunity Away From Moderna?
Pfizer (NYSE: PFE) just scored another first. The U.S. Food and Drug Administration (FDA) granted it authorization for the use of its coronavirus vaccine in a new age group -- 12 through 15. In
Dow Hits $35,000, Crushing the Nasdaq. What Does That Mean for Retirees?
On Monday, the Dow Jones Industrial Average (DJIA) hit an intraday high above the $35,000 mark for the first time in history.
America's oldest stock index has produced a total return just shy of 17%
Is Sanofi a Good Buy in 2021?
The French-based pharmaceutical company Sanofi (NASDAQ: SNY) has been flying under the radar over the past few years as companies like AbbVie, Bristol Myers Squibb, and Merck have dominated the
How Visa Direct Is Modernizing Money
The flow of money is central to modern life. Banks and payments companies play extremely important roles in everything from receiving a paycheck to shopping online. This has never been more true
2 Best Biotech Stocks to Buy Now
Biotech stocks are popular with investors because of their drugs' life-saving benefits and strong intellectual property moats. Current patent laws allow drug developers market exclusivity for two
3 Healthcare Stocks That Might Soar if Biden Gets This Part of His Budget Approved
One of the most notable items in Joe Biden's recent budget proposal is $6.5 billion to create an agency called the Advanced Research Projects Agency for Health, or ARPA-H. The naming is intended to
Is Trulieve Cannabis a Good Buy Ahead of Earnings?
The pandemic-induced marijuana boom helped the U.S. cannabis industry sparkle. Florida-based Trulieve Cannabis (OTC: TCNNF), in particular, impressed investors with its outstanding performance last
This Growing Pot Stock Could Make You Rich in 5 Years
The U.S. cannabis market is still trying navigate its way through what I call the "three Rs of legalization": regulations, real estate, and reality. More and more states are legalizing medical and


